BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31317486)

  • 1. Microangiopathy in Cancer: Causes, Consequences, and Management.
    Thomas MR; Scully M
    Cancer Treat Res; 2019; 179():151-158. PubMed ID: 31317486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-Associated Thrombotic Microangiopathy.
    Aklilu AM; Shirali AC
    Kidney360; 2023 Mar; 4(3):409-422. PubMed ID: 36706238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic Microangiopathy in Cancer.
    Weitz IC
    Semin Thromb Hemost; 2019 Jun; 45(4):348-353. PubMed ID: 31041804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombotic microangiopathy and cancer].
    Kheder El-Fekih R; Deltombe C; Izzedine H
    Nephrol Ther; 2017 Nov; 13(6):439-447. PubMed ID: 28774729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplant-associated thrombotic microangiopathy: Diagnostic challenges and management strategies.
    Elemary M; Sabry W; Seghatchian J; Goubran H
    Transfus Apher Sci; 2019 Jun; 58(3):347-350. PubMed ID: 31097308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic microangiopathy with targeted cancer agents.
    Blake-Haskins JA; Lechleider RJ; Kreitman RJ
    Clin Cancer Res; 2011 Sep; 17(18):5858-66. PubMed ID: 21813634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer.
    George JN; Terrell DR; Vesely SK; Kremer Hovinga JA; Lämmle B
    Presse Med; 2012 Mar; 41(3 Pt 2):e177-88. PubMed ID: 22244728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of transplant-associated thrombotic microangiopathy].
    Ikezoe T
    Rinsho Ketsueki; 2018; 59(10):2307-2314. PubMed ID: 30305540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How I treat microangiopathic hemolytic anemia in patients with cancer.
    Thomas MR; Scully M
    Blood; 2021 Mar; 137(10):1310-1317. PubMed ID: 33512445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer.
    Morton JM; George JN
    J Oncol Pract; 2016 Jun; 12(6):523-30. PubMed ID: 27288467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic microangiopathy and indications for therapeutic plasma exchange.
    Adamski J
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):444-9. PubMed ID: 25696892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.
    Jodele S; Laskin BL; Dandoy CE; Myers KC; El-Bietar J; Davies SM; Goebel J; Dixon BP
    Blood Rev; 2015 May; 29(3):191-204. PubMed ID: 25483393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.
    Khosla J; Yeh AC; Spitzer TR; Dey BR
    Bone Marrow Transplant; 2018 Feb; 53(2):129-137. PubMed ID: 28967899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic microangiopathy in cancer.
    Weitz IC
    Thromb Res; 2018 Apr; 164 Suppl 1():S103-S105. PubMed ID: 29703465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options.
    Kim SS; Patel M; Yum K; Keyzner A
    Transfusion; 2015 Feb; 55(2):452-8. PubMed ID: 25209960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapies.
    Font C; de Herreros MG; Tsoukalas N; Brito-Dellan N; Espósito F; Escalante C; Oo TH;
    Support Care Cancer; 2022 Oct; 30(10):8599-8609. PubMed ID: 35545722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
    Jodele S; Dandoy CE; Myers KC; El-Bietar J; Nelson A; Wallace G; Laskin BL
    Transfus Apher Sci; 2016 Apr; 54(2):181-90. PubMed ID: 27156964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments.
    Wanchoo R; Bayer RL; Bassil C; Jhaveri KD
    Am J Kidney Dis; 2018 Dec; 72(6):857-865. PubMed ID: 30146419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-bone marrow transplant thrombotic microangiopathy.
    Obut F; Kasinath V; Abdi R
    Bone Marrow Transplant; 2016 Jul; 51(7):891-7. PubMed ID: 26974272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Plasma Exchange does not Improve Renal Function in Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: An Institutional Experience.
    Sartain S; Shubert S; Wu MF; Srivaths P; Teruya J; Krance R; Martinez C
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):157-162. PubMed ID: 30144562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.